Literature DB >> 8194363

A new procedure for fundus photography and fluorescein angiography in small laboratory animal eyes.

D DiLoreto1, D A Grover, C del Cerro, M del Cerro.   

Abstract

Increasing interest in retinal research demands continuous improvement of experimental techniques and interpretation. Thus, the purpose of our research was to devise a new method for funduscopic photography and fluorescein angiography in the normal or diseased retina of the small laboratory animal that would produce results comparable in optical quality and field coverage to those obtained in human clinical practice. To enhance the view of the small eye, a 2.2 Volk Panretinal lens was held in apposition to the lens of a clinical fundus camera, the Topcon TRC 50FT, by means of a custom made metal sleeve. Albino mice, albino rats, and pigmented rats were photographed. Fluorescein angiography was performed on pigmented rats. Fluorescein was administered intravenously via the jugular vein at a dose of 5 mg/kg. Various speeds of film and flash settings were used depending on the light source and the pigmentation of the animal. Attachment of the 2.2 Panretinal lens to the clinical fundus camera allowed for more clearly defined fundus photographs of the small laboratory animal, as well as an enlarged field of observation over conventional techniques. Consequently, angiography fields and stages documented in the small laboratory animal approximated those obtained in human clinical practice. This technique facilitates the visualization of small fundi and it allows for a fuller documentation of experimental retinal models.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8194363     DOI: 10.3109/02713689409042411

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  8 in total

1.  Expression of cell adhesion molecules and vascular endothelial growth factor in experimental choroidal neovascularisation in the rat.

Authors:  W Y Shen; M J Yu; C J Barry; I J Constable; P E Rakoczy
Journal:  Br J Ophthalmol       Date:  1998-09       Impact factor: 4.638

2.  A portable, contact animal fundus imaging system based on Rol's GRIN lenses.

Authors:  Victor Hernandez; Thomas Albini; William Lee; Cornelis Rowaan; Derek Nankivil; Esdras Arrieta; Jean-Marie Parel
Journal:  Vet Ophthalmol       Date:  2011-08-08       Impact factor: 1.644

3.  Overexpression of vascular endothelial growth factor (VEGF) in the retinal pigment epithelium leads to the development of choroidal neovascularization.

Authors:  K Spilsbury; K L Garrett; W Y Shen; I J Constable; P E Rakoczy
Journal:  Am J Pathol       Date:  2000-07       Impact factor: 4.307

4.  In vivo imaging of microscopic structures in the rat retina.

Authors:  Ying Geng; Kenneth P Greenberg; Robert Wolfe; Daniel C Gray; Jennifer J Hunter; Alfredo Dubra; John G Flannery; David R Williams; Jason Porter
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-07-02       Impact factor: 4.799

5.  A Novel, Real-Time, In Vivo Mouse Retinal Imaging System.

Authors:  Mark C Butler; Jack M Sullivan
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-11       Impact factor: 4.799

Review 6.  A smartphone based method for mouse fundus imaging.

Authors:  Michael Peng; Bomina Park; Hemavathy Harikrishnan; Sultana N Jahan; Jiannong Dai; Naga Pradeep Rayana; Chenna Kesavulu Sugali; Tasneem P Sharma; Sanae Imanishi; Yoshikazu Imanishi; Timothy W Corson; Weiming Mao
Journal:  Exp Eye Res       Date:  2021-03-03       Impact factor: 3.467

7.  Age-related retinopathy in NRF2-deficient mice.

Authors:  Zhenyang Zhao; Yan Chen; Jian Wang; Paul Sternberg; Michael L Freeman; Hans E Grossniklaus; Jiyang Cai
Journal:  PLoS One       Date:  2011-04-29       Impact factor: 3.240

8.  Novel non-contact retina camera for the rat and its application to dynamic retinal vessel analysis.

Authors:  Dietmar Link; Clemens Strohmaier; Bernd U Seifert; Thomas Riemer; Herbert A Reitsamer; Jens Haueisen; Walthard Vilser
Journal:  Biomed Opt Express       Date:  2011-10-17       Impact factor: 3.732

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.